Average Co-Inventor Count = 5.22
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (16 from 3,685 patents)
2. Astrazeneca Ab (2 from 1,501 patents)
3. Bristol Meyers Squibb Company (1 from 41 patents)
4. Bristol-Myers Squibb Holdings Ireland (0 patent)
19 patents:
1. 9453039 - Crystal structures of SGLT2 inhibitors and processes for preparing same
2. 8802715 - Crystal forms of saxagliptin and processes for preparing same
3. 8513428 - Process for preparing atazanavir bisulfate and novel forms
4. 8501698 - Crystal structures of SGLT2 inhibitors and processes for preparing same
5. 8236847 - Crystal forms of saxagliptin and processes for preparing same
6. 7943656 - Crystal forms of saxagliptin and processes for preparing same
7. 7932379 - Methods of producing C-aryl glucoside SGLT2 inhibitors
8. 7919598 - Crystal structures of SGLT2 inhibitors and processes for preparing same
9. 7838678 - Process for preparing atazanavir bisulfate and novel forms
10. 7829720 - Process for preparing atazanavir bisulfate and novel forms
11. 7381737 - Crystalline forms and process for preparing spiro-hydantoin compounds
12. 7375213 - Methods of producing C-aryl glucoside SGLT2 inhibitors
13. 7241899 - Methods for the preparation, isolation and purification of epothilone B, and X-ray crystal structures of epothilone B
14. 7153879 - Polymorphs of an epothilone analog
15. 6982276 - Polymorphs of an epothilone analog